Safety and immunogenicity of CD40.HIVRI.Env, a dendritic cell-based HIV vaccine, in healthy HIV-uninfected adults: a first-in-human randomized, placebo-controlled, dose-escalation study (ANRS VRI06).
Levy Y, Moog C, Wiedemann A, Launay O, Candotti F, Hardel L, Durand M, Rieux V, Diallo A, Lacabaratz C, Cardinaud S, Zurawski S, Zurawski G, Tomaras GD, Ding S, Centlivre M, Thiebaut R, Pantaleo G, Lelièvre JD, Richert L; ANRS VRI06 Study Group.
Levy Y, et al.
EClinicalMedicine. 2024 Oct 2;77:102845. doi: 10.1016/j.eclinm.2024.102845. eCollection 2024 Nov.
EClinicalMedicine. 2024.
PMID: 39649135
Free PMC article.